These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Check the appropriate box:
|
||||
|
o
|
|
Preliminary Proxy Statement
|
||
|
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||
|
ý
|
|
Definitive Proxy Statement
|
||
|
o
|
|
Definitive Additional Materials
|
||
|
o
|
|
Soliciting Material Pursuant to §240.14a-12
|
||
|
LIFEVANTAGE CORPORATION
|
||||
|
(Name of Registrant as Specified In Its Charter)
|
||||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
||||
|
Payment of Filing Fee (Check the appropriate box):
|
||||
|
ý
|
|
No fee required.
|
||
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5)
|
|
Total fee paid:
|
|
o
|
|
Fee paid previously with preliminary materials.
|
||
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3)
|
|
Filing Party:
|
|
|
|
(4)
|
|
Date Filed:
|
|
1.
|
To elect five directors to hold office for a one-year term expiring at our fiscal year 2017 Annual Meeting of Shareholders or until their respective successors are elected and qualified;
|
|
2.
|
To advise on a non-binding resolution on the Company's compensation of its named executive officers;
|
|
3.
|
To approve an amendment to the Company's amended and restated articles of incorporation to authorize a reverse stock split of the Company's common stock (the “Reverse Stock Split”);
|
|
4.
|
To ratify the appointment of EKS&H LLLP as our independent registered public accounting firm for our fiscal year ending June 30, 2016; and
|
|
5.
|
To conduct any other business properly brought before the meeting.
|
|
Sandy, Utah
|
By Order of our Board of Directors
|
|
September 11, 2015
|
/s/ Garry Mauro
|
|
|
Garry Mauro
|
|
|
Chairman
|
|
|
Page
|
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
|
|
|
INFORMATION CONCERNING VOTING AND SOLICITATION OF PROXY
|
|
|
General
|
|
|
Our Fiscal Year
|
|
|
Why am I receiving these materials?
|
|
|
Where and when is the annual meeting?
|
|
|
What am I voting on?
|
|
|
Who can vote at the annual meeting?
|
|
|
How do I vote?
|
|
|
How many votes do I have?
|
|
|
How are votes counted?
|
|
|
What are broker non-votes?
|
|
|
How many votes are needed to approve each proposal?
|
|
|
What does it mean if I receive more than one proxy card or Notice of Availability?
|
|
|
Can I change my vote after submitting my proxy?
|
|
|
What if I return a proxy card but do not make specific choices?
|
|
|
What is the quorum requirement?
|
|
|
Who is paying for this proxy solicitation?
|
|
|
When are shareholder proposals due for next year's annual meeting?
|
|
|
How can I find out the results of the voting at the annual meeting?
|
|
|
|
|
|
PROPOSAL 1 - ELECTION OF DIRECTORS
|
|
|
PROPOSAL 2 - ADVISORY VOTE AS TO OUR EXECUTIVE COMPENSATION
|
|
|
PROPOSAL 3 - APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED ARTICLES OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK
|
|
|
PROPOSAL 4 - RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
|
|
CORPORATE GOVERNANCE
|
|
|
EXECUTIVE OFFICERS
|
|
|
EXECUTIVE COMPENSATION
|
|
|
AUDIT RELATED MATTERS
|
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
|
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
|
|
|
CODE OF ETHICS
|
|
|
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
|
|
|
HOUSEHOLDING OF PROXY MATERIALS
|
|
|
ANNUAL REPORT ON FORM 10-K
|
|
|
OTHER MATTERS
|
|
|
|
|
|
ANNEX A
: Amendment to the Amended and Restated Articles of Incorporation
|
|
|
•
|
the election of five directors to our board of directors;
|
|
•
|
a non-binding resolution on the Company's compensation of its named executive officers;
|
|
•
|
an amendment to the Company's amended and restated articles of incorporation to authorize a reverse stock split of the Company's common stock (the "Reverse Stock Split"); and
|
|
•
|
the ratification of the selection of the appointment of EKS&H LLLP as our independent registered accounting firm for our fiscal year ending June 30, 2016.
|
|
•
|
Voting Your Proxy By Mail
. To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the pre-addressed, postage-paid envelope provided to you.
|
|
•
|
Voting on the Internet
. To vote on the Internet access http://www.proxyvote.com and follow the on-screen instructions or scan the QR code with your smart phone.
|
|
•
|
Voting by Telephone
. To vote by phone call toll free 1-800-690-6903 from any touch-telephone and follow the instructions.
|
|
•
|
Voting in Person
. To vote in person, come to the annual meeting and we will give you a ballot when you arrive.
|
|
•
|
Directors are elected by a plurality of the votes properly cast in person or by proxy. Cumulative voting is not permitted. The five nominees receiving the highest number of "FOR" votes will be elected. Properly executed
|
|
•
|
The non-binding advisory resolution on the Company’s compensation of its named executive officers will be approved by our shareholders if the votes cast "FOR" the proposal exceed the votes cast "AGAINST" the proposal. Properly executed proxies marked "ABSTAIN" and broker non-votes with respect to this proposal will not be voted and accordingly will have no effect on the outcome of this proposal.
|
|
•
|
The amendment to the Company’s amended and restated articles of incorporation to authorize a reverse stock split of the Company’s common stock will be approved by our shareholders if the votes cast "FOR" the proposal exceed the votes cast "AGAINST" the proposal. Properly executed proxies marked "ABSTAIN" and broker non-votes with respect to this proposal will not be voted and accordingly will have no effect on the outcome of this proposal.
|
|
•
|
The ratification of the selection of EKS&H LLLP as our independent registered public accounting firm for the fiscal year ending June 30, 2016 will be approved by our shareholders if the votes cast "FOR" the proposal exceed the votes cast "AGAINST" the proposal. Properly executed proxies marked "ABSTAIN" and broker non-votes with respect to this proposal will not be voted and accordingly will have no effect on the outcome of this proposal. A broker or other nominee will generally have discretionary authority to vote on this proposal because it is considered a routine matter, and therefore we do not expect broker non-votes with respect to this proposal.
|
|
•
|
You may submit another properly completed proxy card with a later date;
|
|
•
|
You may send a written notice that you are revoking your proxy to our Corporate Secretary at LifeVantage Corporation, Attn: Corporate Secretary, 9785 S. Monroe Street, Suite 300, Sandy, Utah 84070; or
|
|
•
|
You may attend the annual meeting and vote in person. Simply attending the meeting will not, by itself, revoke your proxy.
|
|
Name
|
|
Age
|
|
Position with Company
|
|
Mr. Michael A. Beindorff
|
|
63
|
|
Director
|
|
Mr. David S. Manovich
|
|
63
|
|
Director
|
|
Mr. Garry Mauro
|
|
67
|
|
Director
|
|
Mr. George E. Metzger
|
|
68
|
|
Director
|
|
Mr. Richard Okumoto
|
|
63
|
|
Director
|
|
•
|
the then prevailing trading price and trading volume of our common stock and the anticipated impact of the reverse stock split on the trading market for our common stock;
|
|
Name
|
|
Age
|
|
Position with Company
|
|
Mr. Darren Jensen
|
|
46
|
|
President and Chief Executive Officer
|
|
Mr. Mark Jaggi
|
|
40
|
|
Chief Financial Officer and Treasurer
|
|
Mr. Robert Urban
|
|
55
|
|
Chief Operating Officer
|
|
Mr. Justin Rose
|
|
47
|
|
Chief Sales Officer
|
|
Mr. Ryan Thompson
|
|
44
|
|
Senior Vice President of Business Development
|
|
Ms. Michelle Oborn-Virchow
|
|
34
|
|
Vice President of Human Resources
|
|
NEO
|
|
Position
|
|
Darren Jensen
|
|
President and Chief Executive Officer
(1)
|
|
Robert M. Urban
|
|
Chief Operating Officer
|
|
Douglas C. Robinson
|
|
Former President and Chief Executive Officer
(2)
|
|
David S. Manovich
|
|
Former Interim Executive Vice Chairman
(3)
|
|
David S. Colbert
|
|
Former Chief Financial Officer and Treasurer
(4)
|
|
Robert H. Cutler
|
|
Former General Counsel and Corporate Secretary
(5)
|
|
David N. Phelps
|
|
Former Chief Sales Officer
(6)
|
|
Shawn M. Talbott
|
|
Former Chief Science Officer
(7)
|
|
(1)
|
Mr. Jensen was appointed as our President and Chief Executive Officer effective May 18, 2015.
|
|
(2)
|
Mr. Robinson resigned from his employment with the Company effective February 2, 2015.
|
|
(3)
|
Mr. Manovich served as Interim Executive Vice Chairman (the Company’s principal executive officer) from February 2, 2015 through May 17, 2015.
|
|
(4)
|
Mr. Colbert’s employment with the Company was terminated effective July 3, 2015.
|
|
(5)
|
The Company determined to eliminate the position of General Counsel as part of its executive management team, and Mr. Cutler’s employment with the Company was terminated effective May 8, 2015.
|
|
(6)
|
Mr. Phelps’ employment with the Company was terminated effective July 16, 2015.
|
|
(7)
|
Mr. Talbott resigned from his employment with the Company effective July 1, 2015.
|
|
•
|
Part I-Compensation Principles and Processes
. In this part we describe the important principles, processes and tools that help us determine compensation for our NEOs.
|
|
•
|
Part II-Compensation Components
. In this part we discuss the three material components of NEO compensation -base salary, annual and long-term incentive opportunities - and actual compensation paid or awarded to, or earned by, our NEOs in fiscal 2015.
|
|
•
|
Part III-Other Matters
. In this part we discuss other compensation practices that affect how we compensate our NEOs and actions taken regarding executive compensation after the end of fiscal 2015.
|
|
Nutrisystem
|
Acorda Therapeutics
|
|
Aceto Corporation
|
Gaiam
|
|
Hi-Tech Pharmacal
|
The Medicines Company
|
|
Nutraceutical International
|
Natural Alternatives International
|
|
Depomed
|
Vitacost.com
|
|
Auxilium Pharmaceuticals
|
Omega Protein
|
|
PetMed Express
|
Mannatech
|
|
QuinStreet
|
Genomic Health
|
|
Spectrum Pharmaceuticals
|
|
|
•
|
Reward the NEOs for business and individual performance;
|
|
•
|
Encourage effective short-term performance while balancing long-term focus;
|
|
•
|
Provide a significant portion of total compensation opportunity that is at risk; and
|
|
•
|
Be externally competitive and internally equitable.
|
|
•
|
align NEO's incentives directly with shareholder value;
|
|
•
|
encourage performance that increases long-term shareholder return;
|
|
•
|
serve as a retention tool; and
|
|
•
|
give NEOs a meaningful equity stake in our business.
|
|
•
|
An annual incentive payment for incremental annual revenue from sales of Protandim over prior year revenue for such product in an amount equal to 3% of the positive difference between total net revenue from sales of Protandim for the most recently completed fiscal year and Baseline Revenue (as defined below); and
|
|
•
|
An annual incentive payment for incremental annual revenue from sales of TrueScience Skin Care Regimen products over prior year revenue for such products in an amount equal to 2% of the positive difference between total net revenue from sales of TrueScience Skin Care Regimen for the most recently completed fiscal year and Baseline Revenue.
|
|
•
|
a one-time cash bonus of $300,000 when the Company’s annual net revenue exceeds $300 million;
|
|
•
|
a one-time cash bonus of $400,000 when the Company’s annual net revenue exceeds $400 million; and
|
|
•
|
a one-time cash bonus of $500,000 when the Company’s annual net revenue exceeds $500 million (each of $300 million, $400 million and $500 million, a “Revenue Milestone”).
|
|
Name and Principal Position
|
|
Year
|
|
Salary ($)
|
|
Bonus
($)
|
|
Stock Awards ($)(1)
|
|
All Other Compensation ($)
|
|
Total
($)
|
|||||
|
Darren J. Jensen,
President
|
|
2015
|
|
68,750
|
|
|
451,000
|
|
(3)
|
630,000
|
|
|
2,414
|
|
(4)
|
1,152,164
|
|
|
and Chief Executive Officer
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Robert M. Urban
,
Chief
|
|
2015
|
|
370,000
|
|
|
—
|
|
|
308,000
|
|
|
—
|
|
|
678,000
|
|
|
Operating Officer
|
|
2014
|
|
370,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
370,000
|
|
|
|
|
2013
|
|
346,042
|
|
|
—
|
|
|
587,520
|
|
|
—
|
|
|
933,562
|
|
|
Douglas C. Robinson
,
|
|
2015
|
|
310,388
|
|
|
—
|
|
|
616,000
|
|
|
258,958
|
|
(6)
|
1,185,346
|
|
|
Former President and Chief
|
|
2014
|
|
565,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
565,000
|
|
|
Executive Officer
(5)
|
|
2013
|
|
480,763
|
|
|
33,750
|
|
(7)
|
734,400
|
|
|
—
|
|
|
1,248,913
|
|
|
David S. Manovich
,
Former
|
|
2015
|
|
185,000
|
|
(9)
|
|
|
95,750
|
|
(10)
|
13,194
|
|
(11)
|
293,944
|
|
|
|
Interim Executive Vice
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Chairman
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
David S. Colbert
, Former Chief
|
|
2015
|
|
325,000
|
|
|
—
|
|
|
308,000
|
|
|
—
|
|
|
633,000
|
|
|
Financial Officer
(12)
|
|
2014
|
|
325,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
325,000
|
|
|
|
|
2013
|
|
273,067
|
|
|
—
|
|
|
577,140
|
|
|
—
|
|
|
850,207
|
|
|
Robert H. Cutler
,
Former
|
|
2015
|
|
301,456
|
|
|
—
|
|
|
308,000
|
|
|
58,667
|
|
(14)
|
668,123
|
|
|
General Counsel and Secretary
|
|
2014
|
|
352,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
352,000
|
|
|
(13)
|
|
2013
|
|
309,241
|
|
|
—
|
|
|
763,450
|
|
|
—
|
|
|
1,072,691
|
|
|
David N. Phelps,
Former Chief
|
|
2015
|
|
325,000
|
|
|
—
|
|
|
308,000
|
|
|
—
|
|
|
633,000
|
|
|
Sales Officer
(15)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Shawn Talbott,
Former Chief
|
|
2015
|
|
360,000
|
|
|
—
|
|
|
308,000
|
|
|
—
|
|
|
668,000
|
|
|
Science Officer
(16)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
(1)
|
The amounts in this column represent the aggregate grant date fair value of stock awards granted to the NEO in the applicable fiscal year under our 2010 LTIP and computed in accordance with FASB ASC Topic 718. See Note 8 of the notes to our consolidated financial statements in our Annual Report on Form 10-K filed on September 1, 2015 for a discussion of all assumptions made by the Company in determining the grant date fair values of its equity awards. Each NEO other than Messrs. Jensen and Manovich was granted performance-based RSUs (“PRSUs”) on January 2, 2015, the vesting of which is tied to the Company’s total stockholder return (“TSR”) during each of three consecutive annual performance periods, as described in greater detail in
“Compensation Discussion and Analysis -Part II-Compensation Components-Annual Incentive Plan-Long-Term Incentive Plan”
above.
In accordance with SEC rules, the grant date fair value of an award that is subject to performance conditions is based on the probable outcome of the performance condition.
|
|
(2)
|
Mr. Jensen was hired as our President and CEO in May 2015.
|
|
(3)
|
Reflects a signing bonus paid to Mr. Jensen in connection with the commencement of his employment which is subject to forfeiture in full if, during the first year of his employment, his employment with the Company is either terminated for cause or if he voluntarily terminates his employment for other than good reason.
|
|
(4)
|
Includes temporary living expenses paid by the Company.
|
|
(5)
|
Mr. Robinson resigned from the Company effective February 2, 2015. Mr. Robinson was also a member of our board of directors until his resignation, but did not receive additional compensation for his service in such capacity.
|
|
(6)
|
Represents severance payments made pursuant to Mr. Robinson’s separation agreement.
|
|
(7)
|
Represents a transition bonus paid to Mr. Robinson for his continuous employment through October 1, 2012.
|
|
(8)
|
Mr. Manovich’s employment as our interim Executive Vice Chairman began on February 2, 2015 and ended on May 17, 2015.
|
|
(9)
|
Includes compensation that Mr. Manovich received as a non-employee director in 2015 prior to February 2, 2015.
|
|
(10)
|
Includes $32,750 in grant date fair value for 25,000 shares of restricted stock awarded to Mr. Manovich while he was serving as a non-employee director. As further described in Footnote 6 to the Grants of Plan-Based Awards table, Mr. Manovich voluntarily relinquished and waived all rights to these shares of restricted stock in March 2015.
|
|
(11)
|
Includes temporary living and commuting expenses paid by the Company.
|
|
(12)
|
Mr. Colbert’s employment with the Company was terminated effective July 3, 2015.
|
|
(13)
|
Mr. Cutler’s employment with the Company was terminated effective May 8, 2015. Other compensation includes amounts paid as severance.
|
|
(14)
|
Represents severance payments made pursuant to Mr. Cutler’s separation agreement.
|
|
(15)
|
Mr. Phelps’s employment with the Company was terminated effective July 16, 2015.
|
|
(16)
|
Mr. Talbott resigned from the Company effective July 1, 2015.
|
|
Name
|
Award Type (1)
|
Grant Date
|
Estimated Future Payouts Under Non-Equity Incentive Plan Awards (2)
|
Estimated Future Payouts Under Equity Incentive Plan Awards (#)(3)
|
All Other Stock Awards: Number of Shares Or Units (#) (4)
|
Grant Date Fair Value of Stock and Option Awards ($)(5)
|
||||||||
|
Threshold ($)
|
Target ($)
|
Target (#)
|
Maximum (#)
|
|||||||||||
|
Darren Jensen
|
RSA
|
5/18/2015
|
—
|
|
—
|
|
—
|
|
—
|
|
1,000,000
|
|
630,000
|
|
|
Robert M. Urban
|
AIP
|
N/A
|
55,500
|
|
185,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
PRSU
|
1/2/2015
|
—
|
|
—
|
|
200,000
|
|
400,000
|
|
—
|
|
308,000
|
|
|
Douglas C. Robinson
|
AIP
|
N/A
|
127,125
|
|
423,750
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
PRSU
|
1/2/2015
|
—
|
|
—
|
|
400,000
|
|
800,000
|
|
—
|
|
616,000
|
|
|
David S. Manovich
|
RSA
|
11/19/2014
|
—
|
|
—
|
|
—
|
|
—
|
|
25,000(6)
|
|
32,750
|
|
|
|
RSA
|
2/2/2015
|
—
|
|
—
|
|
—
|
|
—
|
|
50,000
|
|
63,000
|
|
|
David S. Colbert
|
AIP
|
N/A
|
48,750
|
|
162,500
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
PRSU
|
1/2/2015
|
—
|
|
—
|
|
200,000
|
|
400,000
|
|
—
|
|
308,000
|
|
|
Robert H. Cutler
|
AIP
|
N/A
|
52,800
|
|
176,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
PRSU
|
1/2/2015
|
—
|
|
—
|
|
200,000
|
|
400,000
|
|
—
|
|
308,000
|
|
|
David N. Phelps
|
AIP
|
N/A
|
48,750
|
|
162,500
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
PRSU
|
1/2/2015
|
—
|
|
—
|
|
200,000
|
|
400,000
|
|
—
|
|
308,000
|
|
|
Shawn Talbott
|
AIP
|
N/A
|
43,200
|
|
144,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
PRSU
|
1/2/2015
|
—
|
|
—
|
|
200,000
|
|
400,000
|
|
—
|
|
308,000
|
|
|
(1)
|
“AIP” denotes that the award was made pursuant to our fiscal 2015 annual incentive plan. “RSA” denotes an award of restricted stock that was made pursuant to our 2010 LTIP. “PRSU” denotes a performance-based restricted stock unit award that was made pursuant to our 2010 LTIP.
|
|
(2)
|
The annual incentive plan is an annual incentive plan that pays a cash award for performance and is paid within four months of the end of the performance year. See our “
Compensation Discussion and Analysis-Part II-Compensation Components-Annual Incentive Plan
” for a detailed description of annual incentive plan awards. The amounts reported in the Threshold column reflect the potential payout if the Company’s diluted income per share for the fiscal year was at the minimum level required to receive a cash bonus. The amounts reported in the Target column reflect the maximum potential payout if the Company’s diluted income per share for the fiscal year was at the goal performance level and is based on a percentage of the NEO’s base salary set prior to the beginning of the fiscal year. None of our NEOs actually received an award under our annual incentive plan for fiscal 2015.
|
|
(3)
|
Each NEO other than Messrs. Jensen and Manovich was granted PRSUs under the 2010 LTIP. Vesting for the PRSUs is subject to continued service and the Company’s TSR, with one-third of the PRSUs eligible to vest for each of calendar years 2015, 2016 and 2017. Vesting of 50% of the PRSUs is based on the Company’s absolute TSR for the performance period as compared to a matrix of fixed numeric values, and the vesting of the other 50% of the PRSUs is based on a relative comparison of the Company’s TSR to the Vanguard Russell 2000 exchange traded fund. The number of PRSUs eligible to vest in any performance period is 0% to 200% of the target for such calendar year. The number of PRSUs shown in the target column represents the number of PRSUs that will vest if achievement is at 100% for each of the three performance periods, and the maximum reflects achievement at 200%. No threshold is applicable to the PRSUs.
|
|
(4)
|
Messrs. Jensen and Manovich were granted restricted stock under our 2010 LTIP. See our
“Compensation Discussion and Analysis -Part II-Compensation Components-Annual Incentive Plan-Long-Term Incentive Plan”
above and also the Outstanding Equity Awards table below for a description of restricted stock awards under our 2010 LTIP.
|
|
(5)
|
We calculate the grant date fair value of each award in accordance with FASB ASC Topic 718 and as described in Footnote 1 to the “
Summary Compensation Table
,” above. In accordance with SEC rules, the grant date fair value of an award that is subject to a performance condition is based on the probable outcome of the performance condition.
|
|
(6)
|
Granted to Mr. Manovich in connection with this service as a non-employee director. As further described below in “
Director Compensation
,” in March 2015, each of our non-employee directors, including Mr. Manovich, voluntarily relinquished and waived all rights to such restricted stock awards.
|
|
|
Option Awards
|
Stock Awards
|
||||||||||||||
|
Name
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number
of Shares
or Units
of Stock
That Have
Not
Vested
(#)
|
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)(1)
|
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other Rights
That Have
Not Vested
(#)
|
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other Rights
That Have
Not Vested
($)(2)
|
||||||||
|
Darren Jensen
|
—
|
|
—
|
|
—
|
|
—
|
|
1,000,000(3)
|
|
530,000
|
|
—
|
|
—
|
|
|
Robert M. Urban
|
115,625
|
|
34,375
|
|
3.19
|
|
5/29/2022(4)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
3,625(5)
|
|
1,921
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
128,000(6)
|
|
67,840
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
200,000(7)
|
|
106,000
|
|
|
David S. Manovich
|
100,000
|
|
—
|
|
1.33
|
|
1/10/2022(8)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
50,000(9)
|
|
26,500
|
|
—
|
|
—
|
|
|
David S. Colbert
|
—
|
|
—
|
|
—
|
|
—
|
|
41,000(10)
|
|
21,730
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
70,000(6)
|
|
37,100
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
200,000(7)
|
|
106,000
|
|
|
Robert H. Cutler
|
121,875
|
|
—
|
|
2.87
|
|
8/6/2015(11)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
David N. Phelps
|
—
|
|
—
|
|
—
|
|
—
|
|
37,500(12)
|
|
19,875
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
200,000(7)
|
|
106,000
|
|
|
Shawn Talbott
|
—
|
|
—
|
|
—
|
|
—
|
|
37,500(13)
|
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
200,000(7)
|
|
106,000
|
|
|
(1)
|
Computed in accordance with SEC rules as the number of unvested RSAs multiplied by the closing market price of our common stock at the end of the 2015 fiscal year, which was $0.53 on June 30, 2015 (the last business day of the 2015 fiscal year). The actual value (if any) to be realized by the NEO depends on whether the shares vest and the future performance of our common stock.
|
|
(2)
|
Computed in accordance with SEC rules as the number of unvested PRSUs multiplied by the closing market price of our common stock at the end of the 2015 fiscal year, which was $0.53 on June 30, 2015 (the last business day of the 2015 fiscal year). The actual value (if any) to be realized by the NEO depends on whether the performance milestones related thereto are achieved and the future performance of our common stock.
|
|
(3)
|
These shares of restricted stock were granted on May 18, 2015 and vest in full on the third anniversary of Mr. Jensen’s commencement of employment with the Company, assuming continuous employment with the Company through such date.
|
|
(4)
|
This option was granted on May 29, 2012. One-fourth of the shares subject to this option vested on May 29, 2013, and the remaining shares vest in 36 equal monthly installments on the 29th day of each month assuming continuous employment with the Company.
|
|
(5)
|
These shares of restricted stock were granted on May 29, 2012 and vest in four equal annual installments beginning on May 29, 2013 assuming continuous employment with the Company.
|
|
(6)
|
These shares of restricted stock were granted on June 24, 2013 and vest in four equal annual installments beginning on June 24, 2014 assuming continuous employment with the Company.
|
|
(7)
|
The PSUs were granted to Messrs. Urban, Colbert, Talbott and Phelps on January 2, 2015 under the 2010 LTIP. Vesting for the PRSUs is subject to continued service and the Company’s TSR, with one-third of the PRSUs eligible to vest for each of calendar years 2015, 2016 and 2017. Vesting of 50% of the PRSUs is based on the Company’s absolute TSR for the performance period as compared to a matrix of fixed numeric values, and the vesting of the other 50% of the PRSUs is based on a relative comparison of the Company’s TSR to the Vanguard Russell 2000 exchange traded fund. The number of PRSUs eligible to vest in any performance
|
|
(8)
|
This option was granted on January 10, 2012 as compensation for Mr. Manovich’s service as a non-employee director. It vested in twelve equal monthly installments beginning on the date of grant and was fully vested on the date of our 2013 annual meeting of stockholders.
|
|
(9)
|
These shares of restricted stock were granted on February 4, 2015 and vest in full on the first anniversary of the date of grant, assuming continuous service with the Company.
|
|
(10)
|
These shares of restricted stock were granted on August 1, 2012 and vest in four equal annual installments beginning on August 1, 2013 assuming continuous employment with the Company.
|
|
(11)
|
This option was granted on March 15, 2012. One-fourth of the shares subject to this option vested on January 24, 2013, and the remaining shares vested in 36 equal monthly installments on the 24th day of each month until Mr. Cutler’s termination of employment on May 8, 2015.
|
|
(12)
|
These shares of restricted stock were granted on November 18, 2013 and vest in four equal annual installments beginning on November 19, 2014 assuming continuous employment with the Company.
|
|
(13)
|
These shares of restricted stock were granted on January 1, 2014 and vest in four equal annual installments beginning on January 1, 2015 assuming continuous employment with the Company.
|
|
|
Option Awards
|
|
Stock Awards
|
||||||
|
Name
|
Number of Shares Acquired on Exercise (#)
|
Value Realized on Exercise ($)(1)
|
|
Number of Shares Acquired on Vesting (#)
|
Value Realized on Vesting ($)(2)
|
||||
|
Darren Jensen
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
Robert M. Urban
|
—
|
|
—
|
|
|
67,625
|
|
36,983
|
|
|
Douglas C. Robinson
|
53,301
|
|
2,665
|
|
|
—
|
|
—
|
|
|
David S. Manovich
|
—
|
|
—
|
|
|
25,000
|
|
32,750
|
|
|
David S. Colbert
|
—
|
|
—
|
|
|
55,500
|
|
46,370
|
|
|
Robert H. Cutler
|
—
|
|
—
|
|
|
59,207
|
|
72,233
|
|
|
David N. Phelps
|
—
|
|
—
|
|
|
12,500
|
|
16,125
|
|
|
Shawn M. Talbott
|
—
|
|
—
|
|
|
12,500
|
|
16,250
|
|
|
(1)
|
Value realized upon exercise was determined by multiplying the number of stock options exercised by the difference between the fair market value of the underlying stock on the exercise date and the exercise price of the stock options.
|
|
(2)
|
Value realized upon vesting of stock awards was determined by multiplying the number of shares of restricted stock that vested by the fair market value of our common stock on the vesting date.
|
|
•
|
Executive's rate of base salary as of June 30, 2015;
|
|
•
|
Cash out of all stock options (whose vesting is accelerated) at their then intrinsic value as of June 30, 2015;
|
|
•
|
Cash severance as provided under the executive's employment agreement in effect as of June 30, 2015;
|
|
•
|
Change in control occurring on June 30, 2015;
|
|
•
|
Termination of executive's employment occurring on June 30, 2015;
|
|
•
|
A price per share of $0.53 which was the closing price of our common stock on June 30, 2015, the final trading day of fiscal 2015; and
|
|
•
|
The executives' employment agreements that were in effect as of June 30, 2015 were utilized.
|
|
|
|
|
|
|
|
||
|
|
|
Involuntary Termination ($)(1)
|
|
Involuntary Termination within 12 months after a change in control ($)(2)(3)
|
|||
|
Darren Jensen
|
|
|
|
||||
|
Base salary continuation
|
|
275,000
|
|
|
|
550,000
|
|
|
Continuation of health insurance benefits
|
|
—
|
|
|
|
—
|
|
|
Acceleration of vesting of equity awards
|
|
—
|
|
|
|
530,000
|
|
|
Total
|
|
275,000
|
|
|
|
1,080,000
|
|
|
Robert M. Urban
|
|
|
|
||||
|
Base salary continuation
|
|
370,000
|
|
|
|
370,000
|
|
|
Continuation of health insurance benefits
|
|
—
|
|
|
|
—
|
|
|
Acceleration of vesting of equity awards
|
|
—
|
|
|
|
69,761
|
|
|
Total
|
|
370,000
|
|
|
|
439,761
|
|
|
David S. Colbert
|
|
|
|
||||
|
Base salary continuation
|
|
325,000
|
|
|
|
325,000
|
|
|
Continuation of health insurance benefits
|
|
—
|
|
|
|
—
|
|
|
Acceleration of vesting of equity awards
|
|
—
|
|
|
|
58,830
|
|
|
Total
|
|
325,000
|
|
|
|
383,830
|
|
|
David Phelps
|
|
|
|
||||
|
Base salary continuation
|
|
325,000
|
|
|
|
325,000
|
|
|
Continuation of health insurance benefits
|
|
—
|
|
|
|
—
|
|
|
Acceleration of vesting of equity awards
|
|
—
|
|
|
|
19,875
|
|
|
Total
|
|
325,000
|
|
|
|
344,875
|
|
|
Shawn Talbott
|
|
|
|
||||
|
Base salary continuation
|
|
360,000
|
|
|
|
360,000
|
|
|
Continuation of health insurance benefits
|
|
—
|
|
|
|
—
|
|
|
Acceleration of vesting of equity awards
|
|
—
|
|
|
|
19,875
|
|
|
Total
|
|
360,000
|
|
|
|
379,875
|
|
|
(1)
|
For purposes of this table, an involuntary termination consists of, with respect to Messrs. Jensen, Urban, Colbert, Phelps and Talbott, our termination of their respective employment without cause or their resignation for good reason. See
“Compensation Discussion and Analysis-Part III-Other Matters-Employment Agreements.”
|
|
(2)
|
For purposes of this table, an involuntary termination consists of, with respect to Messrs. Robinson, Colbert, Urban and Cutler, our termination of their respective employment without cause or their resignation for good reason. See “
Compensation Discussion and Analysis-Part III-Other Matters-Employment Agreements.
”
|
|
(3)
|
For purposes of this table, an involuntary termination within 12 months after a change in control consists of, with respect to Messrs. Jensen, Urban, Colbert, Phelps and Talbott, the termination of their respective employment for any reason other than for cause, disability, death, presumed death or voluntary termination. See “
Compensation Discussion and Analysis-Part III-Other Matters-Employment Agreements
.”
|
|
|
The Compensation Committee
|
|
|
|
|
|
|
|
George E. Metzger, Chair
|
|
|
|
David S. Manovich
|
|
|
|
Garry Mauro
|
|
|
•
|
Annual Equity Awards - On the date of the next regular annual meeting of stockholders after the annual meeting of stockholders at which a continuing non-employee director is re-elected (the “Election Date”) (for example, for continuing non-employee directors re-elected at and having an Election Date of the fiscal 2016 annual meeting of stockholders, the fiscal 2017 annual meeting of stockholders), each such continuing non-employee director who continues to serve as a member of our board of directors as of immediately prior to the next regular annual meeting of stockholders following the Election Date will receive a fully vested stock award for a number of shares of our common stock determined as follows: $75,000 divided by the “average stock price” and rounded down to the nearest whole share, with the “average stock price” calculated by averaging the closing prices of a
|
|
•
|
Initial Equity Awards - On the one year anniversary of the non-employee director joining our board of directors, each new non-employee director will receive an award for that number of shares of our common stock determined as follows: $150,000 divided by the “average stock price” and rounded down to the nearest whole share, with the “average stock price” calculated by averaging the closing prices of a share of our common stock on the last trading day of the month for each of the twelve months prior to the one year anniversary of the non-employee director joining our board.
|
|
Name
|
|
Fees Earned or Paid in Cash($)
|
|
Stock Awards ($)(1)
|
|
All Other Compensation
|
|
Total($)
|
|||
|
Michael A. Beindorff
|
|
60,000
|
|
|
32,750
|
|
|
—
|
|
92,750
|
|
|
Garry Mauro
|
|
66,000
|
|
|
32,750
|
|
|
—
|
|
98,750
|
|
|
George E. Metzger
|
|
60,000
|
|
|
32,750
|
|
|
—
|
|
92,750
|
|
|
Richard Okumoto
|
|
60,000
|
|
|
32,750
|
|
|
—
|
|
92,750
|
|
|
(1)
|
Following our fiscal 2015 annual meeting of shareholders held on November 19, 2014, we granted each continuing, non-employee director an award of 25,000 shares of restricted stock. Subject to continued service on our board of directors, the awards of restricted stock were scheduled to vest in full on the date of our fiscal 2016 Annual Meeting of Shareholders; however, in March 2015, each of our non-employee directors voluntarily relinquished and waived all rights to such restricted stock awards. The totals shown in this column represent the grant date fair value of each award of restricted stock in accordance with FASB ASC Topic 718 and as described in Footnote 1 to the “
Summary Compensation Table
,” above.
|
|
|
|
Option Awards
|
|||||||
|
Name
|
|
Number of Securities Underlying Unexercised Options (#) Exercisable
|
|
Number of Securities Underlying Unexercised Options (#) Unexercisable
|
|
Option Exercise Price ($)
|
|||
|
Michael A. Beindorff
|
|
100,000
|
|
|
—
|
|
|
1.33
|
|
|
Garry Mauro
|
|
100,000
|
|
|
—
|
|
|
0.30
|
|
|
|
|
120,000
|
|
|
—
|
|
|
0.21
|
|
|
|
|
120,000
|
|
|
—
|
|
|
0.25
|
|
|
|
|
120,000
|
|
|
—
|
|
|
0.80
|
|
|
|
|
100,000
|
|
|
—
|
|
|
1.33
|
|
|
Equity compensation plan approved by security holders
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
|
||||
|
2007 LTIP
|
|
2,079,301
|
|
|
$
|
0.65
|
|
|
33,269
|
|
|
2010 LTIP
|
|
3,698,736
|
|
|
$
|
1.91
|
|
|
4,580,923
|
|
|
All equity compensation plans approved by security holders
|
|
5,778,037
|
|
|
$
|
1.07
|
|
|
4,614,192
|
|
|
|
The Audit Committee
|
|
|
|
|
|
|
|
Richard Okumoto, Chair
|
|
|
|
Michael A. Beindorff
|
|
|
|
Garry Mauro
|
|
|
|
|
Fiscal year ended June 30,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
Audit Fees(1)
|
|
$
|
243,895
|
|
|
$
|
238,237
|
|
|
Audit-Related Fees(2)
|
|
20,000
|
|
|
20,000
|
|
||
|
Tax Fees(3)
|
|
74,636
|
|
|
79,293
|
|
||
|
All Other Fees
|
|
—
|
|
|
—
|
|
||
|
|
|
$
|
338,531
|
|
|
$
|
337,530
|
|
|
(1)
|
Audit Fees consist of fees billed for the audit of annual financial statements and internal control over financial reporting and the review of interim financial statements.
|
|
(2)
|
Audit-Related Fees consist of fees billed for the audit of our employee benefit plan.
|
|
(3)
|
Tax Fees consisted of fees billed for professional services for tax compliance, tax advice and tax planning.
|
|
Name of Beneficial Owner(1)
|
|
Number of Shares
|
|
Percent of Class
|
|
Principal Stockholders
|
|
|
|
|
|
Dell Loy Hansen
|
|
4,982,868(2)
|
|
5.10%
|
|
595 S. Riverwoods Pkwy, Suite 400
|
|
|
|
|
|
Logan, UT 84321
|
|
|
|
|
|
Directors and Named Executive Officers
|
|
|
|
|
|
Michael A. Beindorff
|
|
311,100(3)
|
|
*
|
|
David S. Manovich
|
|
745,537(4)
|
|
*
|
|
Garry P. Mauro
|
|
874,954(5)
|
|
*
|
|
George Metzger
|
|
150,000(6)
|
|
*
|
|
Richard Okumoto
|
|
175,000(7)
|
|
*
|
|
Darren J. Jensen
|
|
1,000,000(8)
|
|
1.02%
|
|
Robert Urban
|
|
330,846(9)
|
|
*
|
|
Douglas C. Robinson
|
|
51,720(10)
|
|
*
|
|
David Colbert
|
|
96,902(11)
|
|
*
|
|
Shawn Talbott
|
|
19,168(12)
|
|
*
|
|
David Phelps
|
|
8,456(13)
|
|
*
|
|
Robert H. Cutler
|
|
111,029(14)
|
|
*
|
|
All executive officers and directors (12 persons)
|
|
3,874,712(15)
|
|
3.96%
|
|
(1)
|
The shares of our common stock beneficially owned are reported on the basis of regulations of the SEC governing the determination of beneficial ownership of securities. Under the rules of the SEC, a person is deemed to be a “beneficial owner” of a security if that person has or shares voting power, which includes the power to vote or direct the voting of such security, or investment power, which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days. Securities that can be so acquired are deemed to be outstanding for purposes of computing such person's ownership percentage, but not for purposes of computing any other person's percentage. Under these rules, more than one person may be deemed beneficial owner of the same securities and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. This table is based upon information supplied by officers, directors and principal shareholders and Schedules 13D and 13G filed with the SEC. Except as otherwise indicated in these footnotes and subject to community property laws where applicable, each of the beneficial owners has, to our knowledge, sole voting and investment power with respect to the indicated shares of common stock. In accordance with the beneficial ownership rules of the SEC, the table does not reflect an aggregate of 145,698 shares of common stock reserved for issuance upon the exercise of outstanding options not exercisable within 60 days held by certain of our executive officers.
|
|
(2)
|
Based solely upon a Schedule 13G filed on July 8, 2015, by Dell Loy Hansen and Hansen Guaranty, LLC. According to the Schedule 13G, Dell Loy Hansen has sole voting and dispositive power with respect to 1,337,000 shares and shared voting and dispositive power with respect to 3,645,868 shares. Hansen Guaranty, LLC has shared voting and dispositive power with respect to 3,645,868 shares.
|
|
(3)
|
Includes 177,000 shares held directly by Mr. Beindorff, 8,000 shares owned by Mr. Beindorff's spouse which he is deemed to beneficially own, 1,100 shares owned by Mr. Beindorff's spouse in a custodial account for their minor children, which Mr. Beindorff is deemed to beneficially own and 25,000 shares pursuant to a Restricted Stock Award. Also includes the following shares which Mr. Beindorff has the right to acquire or will have the right to acquire within 60 days of August 31, 2015 upon the exercise of options: 100,000 shares at an exercise price of $1.33 per share.
|
|
(4)
|
Includes 305,537 shares owned in a joint trust account by Mr. Manovich and his spouse, 35,000 shares owned directly by Mr. Manovich, 40,000 shares held in Mr. Manovich's 401(k) plan, 240,000 shares owned by Mr. Manovich's spouse, which he is deemed to beneficially own, and 25,000 shares directly owned by Mr. Manovich pursuant to a Restricted Stock Award. Also includes the following shares which Mr. Manovich has the right to acquire or will have the right to acquire within 60 days of August 31, 2015 upon the exercise of options: 100,000 shares at an exercise price of $1.33 per share.
|
|
(5)
|
Includes 288,689 shares directly owned by Mr. Mauro, 1,265 shares owned by Mr. Mauro in a custodial account for his minor children, which he is deemed to beneficially own and 25,000 shares directly owned by Mr. Mauro pursuant to a Restricted Stock Award. Also includes the following shares which Mr. Mauro has the right to acquire or will have the right to acquire within 60 days of August 31, 2015 upon the exercise of options: 100,000 shares at an exercise price of $0.30 per share, 120,000 shares at an exercise price of $0.21 per share, 120,000 shares at an exercise price of $0.25 per share, 120,000 shares at an exercise price of $0.80 per share and 100,000 shares at an exercise price of $1.33 per share.
|
|
(6)
|
Consists of 125,000 shares directly owned by Mr. Metzger and 25,000 shares pursuant to a Restricted Stock Award.
|
|
(7)
|
Consists of 150,000 shares directly owned by Mr. Okumoto and 25,000 pursuant to a Restricted Stock Award.
|
|
(8)
|
Consists of 1,000,000 shares directly owned by Mr. Jensen pursuant to a Restricted Stock Award.
|
|
(9)
|
Includes 48,861 shares directly owned by Mr. Urban and 131,625 shares pursuant to a Restricted Stock Awards. Also includes the following shares which Mr. Urban has the right to acquire or will have the right to acquire within 60 days of August 31, 2015 upon the exercise of options: 125,000 at an exercise price of $3.19 per share.
|
|
(10)
|
Consists of 51,720 shares directly owned by Mr. Robinson.
|
|
(11)
|
Consists of 96,902 shares directly owned by Mr. Colbert.
|
|
(12)
|
Consists of 19,168 shares directly owned by Mr. Talbott.
|
|
(13)
|
Consists of 8,456 shares directly owned by Mr. Phelps.
|
|
(14)
|
Includes 110,029 shares directly owned by Mr. Cutler.
|
|
(15)
|
Consists of 2,989,712 shares directly owned by our executive officers and directors as a group and 885,000 shares which our executive officers and directors as a group have the right to acquire or will have the right to acquire within 60 days of August 31, 2015.
|
|
|
By Order of the Board of Directors
|
|
|
September 11, 2015
|
/s/ Beatryx Washington
|
|
|
|
Beatryx Washington
|
|
|
|
Vice President Legal Affairs
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|